Invokana and Osteomyelitis acute - a phase IV clinical study of FDA data

Summary:

Osteomyelitis acute is reported as a side effect among people who take Invokana (canagliflozin), especially for people who are male, 50-59 old, have been taking the drug for 2 - 5 years also take Invokamet, and have Diabetes mellitus inadequate control.

The phase IV clinical study analyzes which people have Osteomyelitis acute when taking Invokana. It is created by eHealthMe based on reports of 29,682 people who have side effects when taking Invokana from the FDA, and is updated regularly.

What is Invokana?

Invokana has active ingredients of canagliflozin. It is often used in diabetes. eHealthMe is studying from 29,937 Invokana users. Check the latest studies of Invokana.

What is Osteomyelitis acute?

Osteomyelitis acute (rapid infection of bone) is found to be associated with 140 drugs and 160 conditions by eHealthMe. Check the latest studies of Osteomyelitis acute.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 24, 2026

29,682 people reported to have side effects when taking Invokana.
Among them, 308 people (1.04%) have Osteomyelitis acute.

Could Invokana cause Osteomyelitis acute?

Among these 308 people:

How long have people been on Invokana when they have Osteomyelitis acute? *

Click here to view more results

What is the gender of people who have Osteomyelitis acute when taking Invokana? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Invokana and have Osteomyelitis acute?

- Check whether Osteomyelitis acute is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Invokana:

Invokana (29,937 reports)

Osteomyelitis acute treatments and more:

Osteomyelitis acute (898 reports)

How severe was Osteomyelitis acute and when was it recovered:

Osteomyelitis acute in Invokana

Expand to all the drugs that have ingredients of canagliflozin:

Osteomyelitis acute and drugs with ingredients of canagliflozin (309 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Invokana:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteomyelitis acute:

Osteomyelitis acute (140 drugs)

Browse all the conditions that are associated with Osteomyelitis acute:

Osteomyelitis acute (160 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on canagliflozin (the active ingredients of Invokana) and Invokana (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.